Figures & data
Table 1. Baseline characteristics overall and by haematinic group (prophylaxis or treatment).
Figure 2. Mean (95%CI) haematocrit according to haematinic group (px – prophylaxis, rx – treatment), gestation (4–40 weeks) and trimester of the first antenatal visit (n = 10,559).
N: 1st tri px 4,371; 2nd tri px 3,199; 3rd tri px 811; 1st tri rx 1,039; 2nd tri rx 941; 3rd tri rx 198.Abbreviations: tri, trimester; px, prophylaxis; tx, treatment.
![Figure 2. Mean (95%CI) haematocrit according to haematinic group (px – prophylaxis, rx – treatment), gestation (4–40 weeks) and trimester of the first antenatal visit (n = 10,559).N: 1st tri px 4,371; 2nd tri px 3,199; 3rd tri px 811; 1st tri rx 1,039; 2nd tri rx 941; 3rd tri rx 198.Abbreviations: tri, trimester; px, prophylaxis; tx, treatment.](/cms/asset/eb47c6f6-c246-4074-a7f4-42668810908a/zgha_a_1621589_f0002_b.gif)
Table 2. Risk factors associated with anaemia at delivery in women in the treatment group who received at least 2 weeks of treatment (n = 2155).